SCHEMBL2389149

SCHEMBL2389149

CCOC(=O)/C=C/c1cc(Br)ccc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.60
KDM4E B2RXH2 4/20 0.60
ALDH1A1 P00352 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
TNFRSF1A P19438 1/20 0.59
LMNA P02545 6/20 0.58
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
NPSR1 Q6W5P4 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2C19 P33261 1/20 0.57
MAOB P27338 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
FDPS P14324 1/20 0.55
HTT P42858 2/20 0.53
ATM Q13315 2/20 0.53
MITF O75030 1/20 0.53
PAX8 Q06710 1/20 0.53
HPGD P15428 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3327236 1.00 MAPT (0.60) MAPTKDM4EALDH1A1SMN1; SMN2TNFRSF1A
SCHEMBL26750820 0.89 MAOB (0.54) MAPTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL8686533 0.85 MAPT (0.65) MAPTKDM4EALDH1A1SMN1; SMN2TNFRSF1A
SCHEMBL5574666 0.84 FDPS (0.56) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL2690713 0.84 FDPS (0.56) KDM4EALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL14143629 0.84 BACE1 (0.69) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL17722573 0.84 MAOB (0.60) KDM4EALDH1A1SMN1; SMN2CYP3A4MAOB
SCHEMBL7111822 0.83 FDPS (0.55) MAPTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL7111819 0.83 FDPS (0.55) MAPTKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL2537052 0.83 TTR (0.58) MAPTKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615514-B1 PROPIONIC ACID DERIVATIVES AND METHODS OF USE THEREOF AVIARA PHARMACEUTICALS INC (US) 2023-11-22 EP disclosed
EP-3567028-B1 BIPHENYL COMPOUND AS CCR2/CCR5 RECEPTOR ANTAGONIST MEDSHINE DISCOVERY INC (CN) 2022-01-05 EP disclosed
EP-3567028-A1 BIPHENYL COMPOUND AS CCR2/CCR5 RECEPTOR ANTAGONIST Medshine Discovery Inc. (CN) 2019-11-13 EP disclosed
US-20120321533-A1 CATALYST ALMQVIST FREDRIK (SE) 2012-12-20 US disclosed
US-20120321533-A1 CATALYST ALMQVIST FREDRIK (SE) 2012-12-20 US disclosed
US-RE42700-E1 Induction of apoptosis in cancer cells SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2011-09-13 US disclosed
US-20100119424-A1 CATALYST ALMQUEST AB (SE) 2010-05-13 US disclosed
WO-2008138938-A2 PROCESS FOR THE PRODUCTION OF PALLADIUM SUPPORTED CATALYSTS FOR CATALYZING HECK, SUZUKI-MIYAURA SONOGASHIRA COUPLING AND BUCHWALD-HARTWIG REACTIONS NORDIC CHEMQUEST AB (SE) 2008-11-20 WO disclosed